Genetic analysis of primary tumour showed IDH1 R132H, TERT C250T, and KRAS G12A (Supplementary Fig. 2), and no mutations in IDH2, H3F3A, or HIST1H3B. MGMT promoter was hypomethylated. The gene discussed is KRAS; the disease is neoplasm.